Trials / Completed
CompletedNCT00120458
Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety
Black Cohosh Therapy for Menopause-Related Anxiety
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will determine the effectiveness of the herb black cohosh for treating menopause-related anxiety symptoms in women. Study hypotheses: 1) Black cohosh will have a superior anti-anxiety effect compared to placebo. 2) Black cohosh will have a comparable safety profile to that of placebo.
Detailed description
During menopause, up to 90% of women will experience symptoms of anxiety, such as nervousness, irritability, fatigue, muscle aches, depression, and low libido. Concern over the safety and effectiveness of hormone replacement therapy for relieving these symptoms has caused many women to seek alternative medical treatments. Data suggest that black cohosh has a direct effect on the neurotransmitters and receptors involved in anxiety. This study will determine whether black cohosh can effectively treat anxiety symptoms in menopausal women. This study will last 12 weeks. Participants will be randomly assigned to receive either black cohosh or placebo daily for the duration of the study. Self-report scales will be used to assess participants' anxiety symptoms and quality of life at the beginning and end of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Black cohosh | 32 to 128 mg (black cohosh) 1 to 4 capsules daily (placebo) |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2005-07-18
- Last updated
- 2010-03-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00120458. Inclusion in this directory is not an endorsement.